Skip to content

Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN75037597
Enrollment
126
Registered
2007-12-04
Start date
2003-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic patients with a peripheral vascular disease Nutritional, Metabolic, Endocrine Diabetic patients with a peripheral vascular disease

Interventions

After a treatment period of 3 months in the Diabetes Unit of the St Carlos Hospital, 63 of the 126 patients were randomly assigned to receive treatment by the family physicians at primary care level a

Sponsors

St Carlos Hospital (Hospital Clínico San Carlos), Department of Endocrinology and Nutrition (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diabetic patients recruited for the foot-care screening programme were tested for peripheral vascular disease and considered eligible when diagnosed. The patients were considered to have a peripheral vascular disease when they had at least one of the following: 1. Patients who underwent a peripheral vascular revascularization at least 6 months ago 2. Patients with previous non-neuropathy foot lesions at least 6 months ago 3. At least one Ankle/Brachial Index (ABI) <0.8

Exclusion criteria

Exclusion criteria: 1. Diabetic patients without peripheral vascular disease 2. Younger than 18 years old or older than 85 years old

Design outcomes

Primary

MeasureTime frame
To estimate the proportion of participants who meet the ATP III and Steno-2 targets of metabolic control, and to compare the difference in trial outcome between the two groups. This will be assessed using the measurements described in the "Interventions" field above.

Secondary

MeasureTime frame
1. Progression of peripheral vascular disease at 60 months 2. New onset of micro and macrovascular complications associated with poorly controlled diabetes at 60 months 3. Morbidity and mortality at 60 months

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026